![Coronavirus (COVID-19): What People With Asthma Need to Know | Asthma and Allergy Foundation of America Coronavirus (COVID-19): What People With Asthma Need to Know | Asthma and Allergy Foundation of America](https://community.aafa.org/fileSendAction/fcType/0/fcOid/557797944946386862/filePointer/579895252604820522/fodoid/579895252604820518/imageType/LARGE/inlineImage/true/387D3086-FF4A-449A-B8F6-A7856C2A36DA.jpeg)
Coronavirus (COVID-19): What People With Asthma Need to Know | Asthma and Allergy Foundation of America
![Inhaled steroids to be tested as a possible treatment for COVID-19 as part of PRINCIPLE trial | NIHR Inhaled steroids to be tested as a possible treatment for COVID-19 as part of PRINCIPLE trial | NIHR](https://www.nihr.ac.uk/images/news/PRINCIPLE-inhaler-budesonide.png)
Inhaled steroids to be tested as a possible treatment for COVID-19 as part of PRINCIPLE trial | NIHR
![Coronavirus (COVID-19): What People With Asthma Need to Know | Asthma and Allergy Foundation of America Coronavirus (COVID-19): What People With Asthma Need to Know | Asthma and Allergy Foundation of America](https://aafa.org/wp-content/uploads/2022/08/respiratory-illness-symptoms-chart-coronavirus-flu-cold-allergies.png)
Coronavirus (COVID-19): What People With Asthma Need to Know | Asthma and Allergy Foundation of America
![Biomedicines | Free Full-Text | Post-COVID-19 Symptoms in Adults with Asthma—Systematic Review Biomedicines | Free Full-Text | Post-COVID-19 Symptoms in Adults with Asthma—Systematic Review](https://pub.mdpi-res.com/biomedicines/biomedicines-11-02268/article_deploy/html/images/biomedicines-11-02268-ag.png?1692865963)
Biomedicines | Free Full-Text | Post-COVID-19 Symptoms in Adults with Asthma—Systematic Review
![Inhaled budesonide for COVID-19 in people at high risk of complications in the community in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial - The Lancet Inhaled budesonide for COVID-19 in people at high risk of complications in the community in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial - The Lancet](https://www.thelancet.com/cms/asset/04c72b94-3d28-44cb-8924-c940e04c424f/gr1.jpg)
Inhaled budesonide for COVID-19 in people at high risk of complications in the community in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial - The Lancet
![Albuterol Inhaler Shortage Due to COVID-19 Could Impact People With Asthma | Asthma and Allergy Foundation of America Albuterol Inhaler Shortage Due to COVID-19 Could Impact People With Asthma | Asthma and Allergy Foundation of America](https://community.aafa.org/fileSendAction/fcType/0/fcOid/569479692535494216/primaryPicture/true/fodoid/571872364885442989/imageType/LARGE/inlineImage/true/coronavirus-albuterol-shortage-asthma-medicine-BT.png)